Видео с ютуба Concord Biotech

Concord Biotech Ltd Q3 FY2025-26 Earnings Conference Call

China+1 Strategy Is Playing Out In CDMO Biz, Could See Rs 2,400 Crore Revenue : Concord Biotech

Concord Biotech's Newest API Facility

Concord Biotech Limited

Buy Cyient At Current Levels? | Concord Biotech: Hold For Recovery | Kunal Bothra Explains | ET Now

Конференция по финансовым результатам Concord Biotech за второй квартал 2026 финансового года

Everything you need to know about Rakesh Jhunjhunwala-Backed Concord Biotech IPO

API manufacturing facility - Limbasi

Concord Biotech- Specializes In Development & Manufacturing Of Active Pharmaceutical Ingredients

Concord Biotech Analysis | Rare Pharma Monopoly in Rakesh Jhunjhunwala Portfolio #sbstocks

Listing Ceremony of Concord Biotech Limited

Exclusive Conversation With Concord Biotech Management Ahead Of IPO Set To Hit Street On Aug 4, 2023

Concord Biotech Q3FY26 Earnings Concall | Concord Biotech Q3FY26 Earnings Conference Call

Concord Biotech listing: Rakesh Jhunjhunwala-backed company makes stellar debut at bourses

ET Markets Exclusive: Concord Biotech's top brass on the upcoming IPO, future plans and more

Concord Biotech Ltd Q3 FY2025-26 Concall

Concord Biotech IPO: Unveiling India's Next Biopharma Success Story!

concord biotech ipo gmp | Concord biotech ipo

API manufacturing Facility - Dholka